Brian D. Wakefield

P2X receptor antagonists for pain management: examination of binding and physicochemical properties

Rebecca J. Gum, Brian D. Wakefield, Michael F. Jarvis · Purinergic Signalling · 2011 · 67 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

<i>cis</i>-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-<i>h</i>]quinazolin-2-amine (A-987306), A New Histamine H₄R Antagonist that Blocks Pain Responses against Carrageenan-Induced Hyperalgesia

Huaqing Liu, Robert J. Altenbach, Tracy L. Carr et al. · Journal of Medicinal Chemistry · 2008 · 48 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Scaffold oriented synthesis. Part 4: Design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing heterocycle forming and multicomponent reactions

Irini Akritopoulou‐Zanze, Brian D. Wakefield, Alan F. Gasiecki et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Discovery and initial development of a novel class of antibacterials: Inhibitors of Staphylococcus aureus transcription/translation

Scott D. Larsen, Matthew R. Hester, J. Craig Ruble et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 22 citations

Pharmacy, Microbiology, Pharmacology +13

Preparation of novel antibacterial agents. Replacement of the central aromatic ring with heterocycles

Jianke Li, Brian D. Wakefield, J. Craig Ruble et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 19 citations

Pharmacy, Chemistry, Medicinal Chemistry +14